Table 3.
Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P-value | OR | 95% CI | p-value | |
Gender | 0.588 | 0.312–1.106 | 0.099 | |||
Age(y) | 1.013 | 0.992–1.035 | 0.232 | |||
TBIL | 1.086 | 1.039–1.134 | < 0.001 | 1.110 | 0.985–1.250 | 0.086 |
AST | 1.232 | 1.175–1.293 | < 0.001 | 1.079 | 0.969–1.200 | 0.166 |
ALT | 1.133 | 1.101–1.167 | < 0.001 | 1.081 | 1.011–1.157 | 0.023 |
ALP | 1.023 | 1.013–1.033 | < 0.001 | 0.997 | 0.970–1.024 | 0.806 |
FPR | 2.082 | 1.783–2.430 | < 0.001 | 2.320 | 1.824–2.949 | < 0.001 |
GPR | 1.748 × 108 | 2.003 × 106–1.525 × 1010 | < 0.001 | 8.260 × 106 | 5.031 × 103–1.356 × 1010 | < 0.001 |
TBIL total bilirubin, ALT alanine aminotransferase, AST aspartate amino transferase, ALP alkaline phosphatase, FPR fibrinogen to pre-albumin ratio, GPR gamma-glutamyl transpeptidase to platelet ratio, CI confidence interval, OR odd ratio, AFP-NHCC alpha-fetoprotein-negative hepatocellular carcinoma